Jazz Pharmaceuticals (JAZZ) EV to EBITDA (2011 - 2026)
Jazz Pharmaceuticals' (JAZZ) EV to EBITDA stood at 8.68 in Q2 2026, down 36.9% from 13.77 a year earlier and down 41.5% from the prior quarter.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) EV to EBITDA (2011 - 2026) Analysis & Trends
On a TTM basis, Jazz Pharmaceuticals' EV to EBITDA came in at 5.86 as of Jun 30, 2026; for FY2025, it was 34.02, up 826.8% from FY2024.
- Across earlier years, EV to EBITDA came in at 3.67 in FY2024 (-27.4%), 5.05 in FY2023 (-69.0%), 16.29 in FY2022 (+62.2%) and 10.05 in FY2021 (-19.7%).
- The Q2 2026 figure is the lowest quarterly EV to EBITDA since Q1 2025.
- On a year-over-year basis, EV to EBITDA rose in four of the last eight quarters, with growth averaging 254.4%.
- Peak year-over-year performance for EV to EBITDA in the last five years was growth of 903.8% in Q3 2025, against a decline of 69.0% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 14.84 (Q1 2026), 34.03 (Q4 2025) and 34.90 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Jazz Pharmaceuticals | 15.47 Bn | 9.29 Bn | 1.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.68 |
| Mar 31, 2026 | 14.84 |
| Dec 31, 2025 | 34.03 |
| Sep 30, 2025 | 34.90 |
| Jun 30, 2025 | 13.77 |
| Mar 31, 2025 | 4.61 |
| Dec 31, 2024 | 3.67 |
| Sep 30, 2024 | 3.48 |
| Jun 30, 2024 | 4.33 |
| Mar 31, 2024 | 5.28 |
| Dec 31, 2023 | 5.05 |
| Sep 30, 2023 | 8.34 |
| Jun 30, 2023 | 9.98 |
| Mar 31, 2023 | 14.13 |
| Dec 31, 2022 | 16.29 |
| Sep 30, 2022 | 8.42 |
| Jun 30, 2022 | 9.87 |
| Mar 31, 2022 | 12.20 |
| Dec 31, 2021 | 10.05 |
| Sep 30, 2021 | 9.73 |
API Access
Jazz Pharmaceuticals EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=JAZZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "JAZZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=JAZZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();